Most recently, Dr. Gilliland served as senior vice president of Merck Research Laboratories and head of Merck’s oncology franchise. In his new role, Dr. Gilliland will work with the health system’s top leaders to create a national model for the delivery of personalized medicine to patients.
More Articles on Pennsylvania Executive Moves:
Thomas Jefferson University Hospitals Names Dr. Stephen Klasko CEO
Ellwood City Hospital CEO Ray Beck Resigns
Summit Health COO Patrick O’Donnell Promoted to CEO
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
